P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content
Citation: BMC Complementary and Alternative Medicine 2012 12(Suppl 1):P36
Volume 12 Supplement 1
Edited by Robert Saper, Ama Boah and David Eisenberg
This conference and proceedings were supported by Grant Number R13AT007128 from the National Center for Complementary and Alternative Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary and Alternative Medicine or the National Institutes of Health.
International Research Congress on Integrative Medicine and Health 2012. Go to conference site.
Portland, Oregon, USA15-18 May 2012
Page 3 of 10